Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 21, Issue 1, Pages 57-63Publisher
IOS PRESS
DOI: 10.3233/JAD-2010-100015
Keywords
Amyloid-beta peptide metabolism; hyperinsulinemia; hyperphosphorylated tau protein; insulin resistance; insulin resistant brain state; metabolic syndrome; type 2 diabetes mellitus
Categories
Funding
- Italian Longitudinal Study on Aging (ILSA) (Italian National Research Council - CNR-Targeted Project on Ageing) [9400419PF40, 95973PF40]
- Ministero della Salute
Ask authors/readers for more resources
Cumulative evidence suggests that metabolic syndrome (MetS) may be important in the development of mild cognitive impairment, vascular dementia, and Alzheimer's disease (AD). As such, these patients might be described as having metabolic-cognitive syndrome - MetS plus cognitive impairment of degenerative or vascular origin. While peripheral insulin resistance appears to be of primary pathophysiological importance in MetS, the definitions of MetS and its components do not include any reference to insulin resistance or hyperinsulinemia. In the present article, we discuss the role of these factors in the development of cognitive decline and dementia, including underlying mechanisms that influence amyloid-beta (A beta) peptide metabolism and tau protein hyperphosphorylation, the principal neuropathological hallmarks of AD. In AD, an age-related desynchronization of biological systems results, involving stress components, cortisol and noradrenaline, reactive oxygen species, and membrane damage as major candidates that precipitates an insulin resistant brain state (IRBS) with decreased glucose/energy metabolism and the increased formation of hyperphosphorylated tau protein and A beta. Unfortunately, it is very difficult to include the measurement of peripheral insulin resistance in the current MetS criteria or the identification of IRBS for the metabolic-cognitive syndrome. However, since inflammation has been suggested among the MetS components, we propose IRBS as an additional feature of the metabolic-cognitive syndrome to also identify a molecular profile in patients at high risk of developing predementia or dementia syndromes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available